Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway
Authors
Keywords
-
Journal
SCIENCE
Volume 361, Issue 6405, Pages eaao3048
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-08-31
DOI
10.1126/science.aao3048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An immediate–late gene expression module decodes ERK signal duration
- (2017) Florian Uhlitz et al. Molecular Systems Biology
- MAPK kinase signalling dynamics regulate cell fate decisions and drug resistance
- (2016) Nora Rauch et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Interrogating cellular perception and decision making with optogenetic tools
- (2016) Lukasz J. Bugaj et al. JOURNAL OF CELL BIOLOGY
- Schedule-dependent interaction between anticancer treatments
- (2016) Sheng-hong Chen et al. SCIENCE
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Noise Facilitates Transcriptional Control under Dynamic Inputs
- (2015) Ryan A. Kellogg et al. CELL
- Receptor Level Mechanisms Are Required for Epidermal Growth Factor (EGF)-stimulated Extracellular Signal-regulated Kinase (ERK) Activity Pulses
- (2015) Breanne Sparta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RAF inhibitors that evade paradoxical MAPK pathway activation
- (2015) Chao Zhang et al. NATURE
- Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin
- (2015) Toru Hiratsuka et al. eLife
- Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study
- (2014) James Larkin et al. LANCET ONCOLOGY
- Light-Mediated Kinetic Control Reveals the Temporal Effect of the Raf/MEK/ERK Pathway in PC12 Cell Neurite Outgrowth
- (2014) Kai Zhang et al. PLoS One
- Accurate information transmission through dynamic biochemical signaling networks
- (2014) J. Selimkhanov et al. SCIENCE
- Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module
- (2013) Jared E. Toettcher et al. CELL
- The Dynamics of Signaling as a Pharmacological Target
- (2013) Marcelo Behar et al. CELL
- Encoding and Decoding Cellular Information through Signaling Dynamics
- (2013) Jeremy E. Purvis et al. CELL
- Stochastic ERK Activation Induced by Noise and Cell-to-Cell Propagation Regulates Cell Density-Dependent Proliferation
- (2013) Kazuhiro Aoki et al. MOLECULAR CELL
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Raf Inhibitors Target Ras Spatiotemporal Dynamics
- (2012) Kwang-jin Cho et al. CURRENT BIOLOGY
- Frequency-Modulated Pulses of ERK Activity Transmit Quantitative Proliferation Signals
- (2012) John G. Albeck et al. MOLECULAR CELL
- RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
- (2012) Fei Su et al. NEW ENGLAND JOURNAL OF MEDICINE
- p53 Dynamics Control Cell Fate
- (2012) J. E. Purvis et al. SCIENCE
- Light-based feedback for controlling intracellular signaling dynamics
- (2011) Jared E Toettcher et al. NATURE METHODS
- Signal-dependent dynamics of transcription factor translocation controls gene expression
- (2011) Nan Hao et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Feedback Phosphorylation and Raf Heterodimerization on Normal and Mutant B-Raf Signaling
- (2009) D. A. Ritt et al. MOLECULAR AND CELLULAR BIOLOGY
- Dynamics and Variability of ERK2 Response to EGF in Individual Living Cells
- (2009) Cellina Cohen-Saidon et al. MOLECULAR CELL
- A dimerization-dependent mechanism drives RAF catalytic activation
- (2009) Thanashan Rajakulendran et al. NATURE
- Pulsatile Stimulation Determines Timing and Specificity of NF- B-Dependent Transcription
- (2009) L. Ashall et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now